Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (41)
Jason Chiang, Po-Chun Chen, Janet Pham, Cat-Quynh Nguyen, Kawaljit Kaur, Steven S. Raman & Anahid Jewett. (2023) Characterizing hepatocellular carcinoma stem markers and their corresponding susceptibility to NK-cell based immunotherapy. Frontiers in Immunology 14.
Crossref
Crossref
Minting Wen, Yingjing Li, Xiaonan Qin, Bing Qin & Qiong Wang. (2023) Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota. Cells 12:14, pages 1882.
Crossref
Crossref
Kawaljit Kaur, Po-Chun Chen, Meng-Wei Ko, Ao Mei, Emanuela Senjor, Subramaniam Malarkannan, Janko Kos & Anahid Jewett. (2023) Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice. Frontiers in Immunology 14.
Crossref
Crossref
Jane Chuprin, Hannah Buettner, Mina O. Seedhom, Dale L. Greiner, James G. Keck, Fumihiko Ishikawa, Leonard D. Shultz & Michael A. Brehm. (2023) Humanized mouse models for immuno-oncology research. Nature Reviews Clinical Oncology 20:3, pages 192-206.
Crossref
Crossref
Li Zhang & Chang Liu. 2023. Natural Killer Cells - Lessons and Challenges. Natural Killer Cells - Lessons and Challenges.
Kawaljit Kaur, Yujie Sun, Keiichi Kanayama, Kenzo Morinaga, Akishige Hokugo, Ichiro Nishimura & Anahid Jewett. (2023) Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ. Frontiers in Endocrinology 14.
Crossref
Crossref
Kawaljit Kaur & Anahid Jewett. (2023) Supercharged NK Cell-Based Immuotherapy in Humanized Bone Marrow Liver and Thymus (Hu-BLT) Mice Model of Oral, Pancreatic, Glioblastoma, Hepatic, Melanoma and Ovarian Cancers. Critical Reviews in Immunology 43:2, pages 13-25.
Crossref
Crossref
Dipnarine Maharaj, Kawaljit Kaur, Adrian Saltese & Jacqueline Gouvea. (2023) Personalized Precision Immunotherapy for Amyotrophic Lateral Sclerosis (ALS). Critical Reviews in Immunology 43:2, pages 1-11.
Crossref
Crossref
Kawaljit Kaur, Po-Chun Chen, Meng-Wei Ko, Ao Mei, Sara Huerta-Yepez, Dipnarine Maharaj, Subramaniam Malarkannan & Anahid Jewett. (2023) Successes and Challenges in Taming the Beast: Cytotoxic Immune Effectors in Amyotrophic Lateral Sclerosis. Critical Reviews in Immunology 43:1, pages 1-11.
Crossref
Crossref
Po-Chun Chen, Kawaljit Kaur, Meng-Wei Ko, Sara Huerta-Yepez, Yash Jain & Anahid Jewett. (2023) Regulation of Cytotoxic Immune Effector Function by AJ3 Probiotic Bacteria in Amyotrophic Lateral Sclerosis (ALS). Critical Reviews in Immunology 43:1, pages 13-26.
Crossref
Crossref
Emanuela Senjor, Meng-Wei Ko, Kawaljit Kaur, Po-Chun Chen, Barbara Breznik, Nishant Chovatiya, Janko Kos & Anahid Jewett. 2023. NK Cells in Cancer Immunotherapy: Successes and Challenges. NK Cells in Cancer Immunotherapy: Successes and Challenges
3
25
.
Kawaljit Kaur & Anahid Jewett. (2022) Differences in Tumor Growth and Differentiation in NSG and Humanized-BLT Mice; Analysis of Human vs. Humanized-BLT-Derived NK Expansion and Functions. Cancers 15:1, pages 112.
Crossref
Crossref
Nishant Chovatiya, Kawaljit Kaur, Sara Huerta-Yepez, Po-Chun Chen, Adam Neal, Gabriella DiBernardo, Serhat Gumrukcu, Sanaz Memarzadeh & Anahid Jewett. (2022) Inability of ovarian cancers to upregulate their MHC-class I surface expression marks their aggressiveness and increased susceptibility to NK cell-mediated cytotoxicity. Cancer Immunology, Immunotherapy 71:12, pages 2929-2941.
Crossref
Crossref
Meng-Wei Ko, Barbara Breznik, Emanuela Senjor & Anahid Jewett. (2022) Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells. Advances in Cancer Biology - Metastasis 5, pages 100043.
Crossref
Crossref
Barbara Breznik, Meng-Wei Ko, Christopher Tse, Po-Chun Chen, Emanuela Senjor, Bernarda Majc, Anamarija Habič, Nicolas Angelillis, Metka Novak, Vera Župunski, Jernej Mlakar, David Nathanson & Anahid Jewett. (2022) Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres. Communications Biology 5:1.
Crossref
Crossref
Kawaljit Kaur, Keiichi Kanayama, Qing-Qing Wu, Serhat Gumrukcu, Ichiro Nishimura & Anahid Jewett. (2022) Zoledronic acid mediated differential activation of NK cells in different organs of WT and Rag2 mice; stark differences between the bone marrow and gingivae. Cellular Immunology 375, pages 104526.
Crossref
Crossref
Meng-Wei Ko, Kawaljit Kaur, Tahmineh Safaei, Wuyang Chen, Christine Sutanto, Paul Wong & Anahid Jewett. (2022) Defective Patient NK Function Is Reversed by AJ2 Probiotic Bacteria or Addition of Allogeneic Healthy Monocytes. Cells 11:4, pages 697.
Crossref
Crossref
Young Eun Lee, Chae Min Yuk, Minseok Lee, Ki-Cheol Han, Eunsung Jun, Tae Sung Kim, Ja-Lok Ku, Sung G. Im, Eunjung Lee & Mihue Jang. (2022) Facile discovery of a therapeutic agent for NK-mediated synergistic antitumor effects using a patient-derived 3D platform. Biomaterials Science 10:3, pages 678-691.
Crossref
Crossref
Kawaljit Kaur, Po-Chun Chen, Meng-Wei Ko & Anahid Jewett. (2022) The Role of Checkpoint Inhibitors in Autoimmune Diseases: Similarities and Differences Compared with Cancer. Critical Reviews in Immunology 42:3, pages 23-36.
Crossref
Crossref
Deepti Singh, Mohammad Afsar Khan & Hifzur R. Siddique. (2021) Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers. Life Sciences 285, pages 120008.
Crossref
Crossref
Kari A. Shaver, Tayler J. Croom-Perez & Alicja J. Copik. (2021) Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Crossref
Bernarda Majc, Metka Novak, Nataša Kopitar-Jerala, Anahid Jewett & Barbara Breznik. (2021) Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development. Cells 10:2, pages 265.
Crossref
Crossref
Kawaljit Kaur, Tahmineh Safaie, Meng-Wei Ko, Yuhao Wang & Anahid Jewett. (2021) ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor. Cancers 13:2, pages 239.
Crossref
Crossref
Dipnarine Maharaj, Gayathri Srinivasan, Maria M. Abreu, Meng-Wei Ko, Anahid Jewett & Jacqueline Gouvea. (2020) Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor Prognosis IGHV—Unmutated Chronic Lymphocytic Leukemia. Cells 10:1, pages 10.
Crossref
Crossref
Marvin Huynhle & Kawaljit Kaur. (2020) Eating Healthy Might Help the Immune System Fight Cancer. Frontiers for Young Minds 8.
Crossref
Crossref
Kawaljit Kaur, Meng-Wei Ko, Nick Ohanian, Jessica Cook & Anahid Jewett. (2020) Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells. Scientific Reports 10:1.
Crossref
Crossref
Wan Nur Fatihah Wan Mohd Kamaluddin, Nurul Alia Risma Rismayuddin, Ahmad Faisal Ismail, Edre Mohamad Aidid, Noratikah Othman, Noor Afifah Hanin Mohamad & Mohd Hafiz Arzmi. (2020) Probiotic inhibits oral carcinogenesis: A systematic review and meta-analysis. Archives of Oral Biology 118, pages 104855.
Crossref
Crossref
Anahid Jewett. (2020) The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions. Frontiers in Immunology 11.
Crossref
Crossref
Yuanlin Wu, Jing Li, Parham Jabbarzadeh Kaboli, Jing Shen, Xu Wu, Yueshui Zhao, Huijiao Ji, Fukuan Du, Yejiang Zhou, Yongzhou Wang, Hanyu Zhang, Jianhua Yin, Qinglian Wen, Chi Hin Cho, Mingxing Li & Zhangang Xiao. (2020) Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy. Pharmacological Research 155, pages 104691.
Crossref
Crossref
Rowa Y. Alhabbab. (2020) Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells. Frontiers in Genetics 11.
Crossref
Crossref
Dong Jun Park, Pil Soo Sung, Jung-Hee Kim, Gil Won Lee, Jeong Won Jang, Eun Sun Jung, Si Hyun Bae, Jong Young Choi & Seung Kew Yoon. (2020) EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1. Journal for ImmunoTherapy of Cancer 8:1, pages e000301.
Crossref
Crossref
Anahid Jewett, Janko Kos, Kawaljit Kaur, Tahmineh Safaei, Christine Sutanto, Wuyang Chen, Paul Wong, Artin Keshishian Namagerdi, Changge Fang, Yuman Fong & Meng-Wei Ko. (2020) Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis. Molecular Therapy - Oncolytics 16, pages 41-52.
Crossref
Crossref
Yuan-yuan Jin, Wen-zhuo Yang, Sen Zou, Zheng-yang Sun, Chun-tao Wu & Zhao-yong Yang. (2020) Chemoradiotherapy combined with NK cell transfer in a patient with recurrent and metastatic nasopharyngeal carcinoma inducing long-term tumor control. Medicine 99:43, pages e22785.
Crossref
Crossref
Kawaljit Kaur, Anna Karolina Kozlowska, Paytsar Topchyan, Meng-Wei Ko, Nick Ohanian, Jessica Chiang, Jessica Cook, Phyu Ou Maung, So-Hyun Park, Nicholas Cacalano, Changge Fang & Anahid Jewett. (2019) Probiotic-Treated Super-Charged NK Cells Efficiently Clear Poorly Differentiated Pancreatic Tumors in Hu-BLT Mice. Cancers 12:1, pages 63.
Crossref
Crossref
Chuanbao Cui, Kaiwen Fu, Lu Yang, Shuzhi Wu, Zuojie Cen, Xingxing Meng, Qiongguang Huang & Zhichun Xie. (2019) Hypoxia-inducible gene 2 promotes the immune escape of hepatocellular carcinoma from nature killer cells through the interleukin-10-STAT3 signaling pathway. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Sooyeon Oh, Joo-Ho Lee, KyuBum Kwack & Sang-Woon Choi. (2019) Natural Killer Cell Therapy: A New Treatment Paradigm for Solid Tumors. Cancers 11:10, pages 1534.
Crossref
Crossref
Ilaria Roato & Massimo Vitale. (2019) The Uncovered Role of Immune Cells and NK Cells in the Regulation of Bone Metastasis. Frontiers in Endocrinology 10.
Crossref
Crossref
Gaurav Nayyar, Yaya Chu & Mitchell S. Cairo. (2019) Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors. Frontiers in Oncology 9.
Crossref
Crossref
Anahid Jewett, Janko Kos, Yuman Fong, Meng-Wei Ko, Tahmineh Safaei, Milica Perišić Nanut & Kawaljit Kaur. (2018) NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis. Seminars in Cancer Biology 53, pages 178-188.
Crossref
Crossref
Kawaljit Kaur, Hui-Hua Chang, Paytsar Topchyan, Jessica Morgan Cook, Andre Barkhordarian, Guido Eibl & Anahid Jewett. (2018) Deficiencies in Natural Killer Cell Numbers, Expansion, and Function at the Pre-Neoplastic Stage of Pancreatic Cancer by KRAS Mutation in the Pancreas of Obese Mice. Frontiers in Immunology 9.
Crossref
Crossref
Kawaljit Kaur, Milica Perišić Nanut, Meng-Wei Ko, Tahmineh Safaie, Janko Kos & Anahid Jewett. (2018) Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy. Current Opinion in Immunology 51, pages 170-180.
Crossref
Crossref